Inosine 5′-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cells

Clinica Chimica Acta

Volumn 364, Issue 1-2, 2006, Pages 139-147

  Dubsky, Peter C ^a   Friedl, Josef ^a   Stift, Anton ^a   Bachleitner Hofmann, Thomas ^a   Jakesz, Raimund ^a   Gnant, Michael F X ^a   Weigel, Guenter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Dendritic cells; GTP; Immunosuppression; IMPDH; Mycophenolic acid

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; GUANOSINE TRIPHOSPHATE; INOSINATE DEHYDROGENASE; INTERCELLULAR ADHESION MOLECULE 1; MYCOPHENOLIC ACID; NUCLEOTIDE; ADENOSINE TRIPHOSPHATE; BIOLOGICAL MARKER; ENZYME INHIBITOR; LEUKOCYTE ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DOSE RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; MONONUCLEAR CELL;

ADENOSINE TRIPHOSPHATE; ANTIGENS, CD; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLOW CYTOMETRY; GUANOSINE TRIPHOSPHATE; HUMANS; IMMUNOPHENOTYPING; IMP DEHYDROGENASE; LEUKOCYTES, MONONUCLEAR; MYCOPHENOLIC ACID; T-LYMPHOCYTES;

EID: 31044434389     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2005.05.037     Document Type: Article

References (37)

1. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 6673 1998 245 252
2. R.M. Steinman, and M.C. Nussenzweig Inaugural article: avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance Proc Natl Acad Sci U S A 99 1 2002 351 358
3. J. Banchereau, F. Briere, and C. Caux Immunobiology of dendritic cells Annu Rev Immunol 18 2000 767 811
4. L. Fong, and E.G. Engleman Dendritic cells in cancer immunotherapy Annu Rev Immunol 18 2000 245 273
5. A. Mehling, S. Grabbe, M. Voskort, T. Schwarz, T.A. Luger, and S. Beissert Mycophenolate mofetil impairs the maturation and function of murine dendritic cells J Immunol 165 5 2000 2374 2381
6. A.C. Allison, and E.M. Eugui Mycophenolate mofetil and its mechanisms of action Immunopharmacology 47 2-3 2000 85 118
7. C. Schneider, R. Gold, K. Reiners, and K.V. Toyka Mycophenolate mofetil in the therapy of severe myasthenia gravis Eur Neurol 46 2 2001 79 82
8. P.D. Richardson, P.D. James, and S.D. Ryder Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine J Hepatol 33 3 2000 371 375
9. N. Mowzoon, A. Sussman, and W.G. Bradley Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis J Neurol Sci 185 2 2001 119 122
10. W. Miehsler, W. Reinisch, G. Moser, A. Gangl, and H. Vogelsang Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease? Am J Gastroenterol 96 3 2001 782 787
11. M.N. Meriggioli, and J. Rowin Treatment of myasthenia gravis with mycophenolate mofetil: a case report Muscle Nerve 23 8 2000 1287 1289
12. D. Jayne Non-transplant uses of mycophenolate mofetil Curr Opin Nephrol Hypertens 8 5 1999 563 567
13. R.A. Hauser, A.R. Malek, and R. Rosen Successful treatment of a patient with severe refractory myasthenia gravis using mycophenolate mofetil Neurology 51 3 1998 912 913
14. C.C. Geilen, H. Orfanos-Boeckel, G. Offermann, and C.E. Orfanos Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses Hautarzt 51 2 2000 63 69
15. A. Dhawan, and G. Mieli-Vergani Mycophenolate mofetil-a new treatment for autoimmune hepatitis? J Hepatol 33 3 2000 480 481
16. E. Ciafaloni, J.M. Massey, B. Tucker-Lipscomb, and D.B. Sanders Mycophenolate mofetil for myasthenia gravis: an open-label pilot study Neurology 56 1 2001 97 99
17. V. Chaudhry, D.R. Cornblath, J.W. Griffin, R. O'Brien, and D.B. Drachman Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases Neurology 56 1 2001 94 96
18. C. Caponnetto, E. Rossi, and A. Primavera Mycophenolate mofetil: a new immunosuppressive approach. Successful treatment in a case of myasthenia gravis associated with incomplete lupus erythematosus syndrome and hepatitis C virus infection Eur Neurol 46 1 2001 53 54
19. D. Adu, J. Cross, and D.R. Jayne Treatment of systemic lupus erythematosus with mycophenolate mofetil Lupus 10 3 2001 203 208
20. G. Weigel, A. Griesmacher, A.O. Zuckermann, G. Laufer, and M.M. Mueller Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients Clin Pharmacol Ther 69 3 2001 137 144
21. A.C. Allison, and E.M. Eugui Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF) Clin Transplant 10 1 Pt 2 1996 77 84
22. R.C. Garcia, P. Leoni, and A.C. Allison Control of phosphoribosylpyrophosphate synthesis in human lymphocytes Biochem Biophys Res Commun 77 3 1977 1067 1073
23. M. Nagai, Y. Natsumeda, and G. Weber Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells Cancer Res 52 2 1992 258 261
24. Y. Konno, Y. Natsumeda, and M. Nagai Expression of human IMP dehydrogenase types I and II in Escherichia coli and distribution in human normal lymphocytes and leukemic cell lines J Biol Chem 266 1 1991 506 509
25. M. Colic, Z. Stojic-Vukanic, B. Pavlovic, D. Jandric, and I. Stefanoska Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells Clin Exp Immunol 134 1 2003 63 69
26. A. Stift, J. Friedl, and P. Dubsky Dendritic cell-based vaccination in solid cancer J Clin Oncol 21 1 2003 135 142
27. T. Bachleitner-Hofmann, A. Stift, and J. Friedl Stimulation of autologous antitumor T-cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cells J Clin Endocrinol Metab 87 3 2002 1098 1104
28. G. Weigel, A. Griesmacher, R.A. DeAbreu, E. Wolner, and M.M. Mueller Azathioprine and 6-mercaptopurine alter the nucleotide balance in endothelial cells Thromb Res 94 2 1999 87 94
29. G. Seebacher, G. Weigel, and E. Wolner A simple HPLC method for monitoring mycophenolic acid and its glucuronidated metabolite in transplant recipients Clin Chem Lab Med 37 4 1999 409 415
30. + dendritic cells Proc Natl Acad Sci U S A 93 6 1996 2588 2592
31. + leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4 J Leukoc Biol 59 2 1996 208 218
32. A. Griesmacher, G. Weigel, G. Seebacher, and M.M. Muller IMP-dehydrogenase inhibition in human lymphocytes and lymphoblasts by mycophenolic acid and mycophenolic acid glucuronide Clin Chem 43 12 1997 2312 2317
33. R.M. Steinman, S. Turley, I. Mellman, and K. Inaba The induction of tolerance by dendritic cells that have captured apoptotic cells J Exp Med 191 3 2000 411 416
34. E.M. Eugui, A. Mirkovich, and A.C. Allison Lymphocyte-selective antiproliferative and immunosuppressive activity of mycophenolic acid and its morpholinoethyl ester (RS-61443) in rodents Transplant Proc 23 2 Suppl 2 1991 15 18
35. A. Bishara, C. Brautbar, and A. Nagler Prediction by a modified mixed leukocyte reaction assay of graft-versus-host disease and graft rejection after allogeneic bone marrow transplantation Transplantation 57 10 1994 1474 1479
36. P. Bertalanffy, P. Dubsky, E. Wolner, and G. Weigel Alterations of endothelial nucleotide levels by mycophenolic acid result in changes of membrane glycosylation and E-selectin expression Clin Chem Lab Med 37 3 1999 259 264
37. M. Lechmann, E. Kremmer, H. Sticht, and A. Steinkasserer Overexpression, purification, and biochemical characterization of the extracellular human CD83 domain and generation of monoclonal antibodies Protein Expr Purif 24 3 2002 445 452